Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity-Reference-Cited by-同舟云学术

Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity

Published:2024-03-27 Issue:5 Volume:15 Page:1169-1186
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Klein Klara R.^ORCID,Abrahamsen Trine J.^ORCID,Kahkoska Anna R.^ORCID,Alexander G. Caleb^ORCID,Chute Christopher G.^ORCID,Haendel Melissa^ORCID,Hong Stephanie S.^ORCID,Mehta Hemalkumar^ORCID,Moffitt Richard^ORCID,Stürmer Til^ORCID,Kvist Kajsa^ORCID,Buse John B.^ORCID,

Funder

National Center for Advancing Translational Sciences

National Institute on Aging

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13300-024-01562-1.pdf

Reference33 articles.

1. Hartmann-Boyce J, Rees K, Perring JC, et al. Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews. Diabetes Care. 2021;44(12):2790–811.

2. Floyd JS, Walker RL, Kuntz JL, et al. Association between diabetes severity and risks of COVID-19 infection and outcomes. J Gen Intern Med. 2023;38(6):1484–92.

3. de Almeida-Pititto B, Dualib PM, Zajdenverg L, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr. 2020;12:75.

4. Singh AK, Khunti K. COVID-19 and diabetes. Annu Rev Med. 2022;73:129–47.

5. Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, Klonoff DC. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813–21.